Proactive Investors - Run By Investors For Investors

Tidal Royalty expects to resume trading on OTC Markets after FINRA application

The SEC had revoked the registration of the common shares of its predecessor company, Elkhorn Gold Mining Corp, for filing deficiencies, according to Tidal Royalty
A marijuana plant
The company provides royalty financing for the legal cannabis industry

Tidal Royalty Corp (CSE:RLTY.U) said it expects to resume trading on the OTC Markets in the US after filing an application with the Financial Industry Regulatory Authority.

The Toronto-based provider of royalty financing for the legal cannabis industry said Monday in a press release that the Securities and Exchange Commission advised it in December that the agency had completed its review of the company’s registration statement.

READ: Tidal Royalty set to file registration statement with SEC; looks to reinstate shares on OTC

Tidal Royalty added that the registration statement is effective and rectifies the filing deficiencies of its predecessor entity.

In September, the OTC Markets stopped listing its common shares under the symbol TDRYF. The SEC had revoked the registration of the common shares of a predecessor company, Elkhorn Gold Mining Corp, for filing deficiencies, according to Tidal Royalty.

Shares of Tidal Royalty climbed C$0.01 to C$0.10 in Monday’s Canadian trading.

Contact Dennis Fitzgerald at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full RLTY.U profile View Profile

Tidal Royalty Corp. Timeline

Related Articles

RYAH vaporizer and cartridges
May 16 2019
RYAH is the first cannabis vaporizer that lets users precisely regulate dose and temperature
cannabis bud on tray
April 25 2019
Armed with a new partnership with Canada's largest pharmacy and an international cultivator, Flowr is aiming to provide medicinal and recreational consumers around the world with premium, high-quality cannabis
cannabis tablet
February 28 2019
The company fills a niche in the medicinal cannabis market, as it continues to push forward its suite of precision oral dose products
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use